Common Contracts
1 similar Clinical Study Agreement contracts
CLINICAL STUDY AGREEMENT PROTOCOL: AR-105-002 SITE: 203-003 XXXXXXX ARIDIS PHARMACEUTICALS, INC. 05-SEPTEMBER-2017 VERSION: VERSION#1 COUNTRY: CZECH REPUBLIC SMLOUVA O KLINICKÉ STUDII PROTOKOL: AR-105-002 PRACOVIŠTĚ: 203-003 XXXXXX ARIDIS...Clinical Study Agreement • September 12th, 2017
CLINICAL STUDY AGREEMENTThis clinical study agreement (“Agreement”), effective as of date of publishing in contract registar (the “Effective Date”), is entered into by and amongMedpace Clinical Research, LLC, with its principal office and place of business at 5375 Medpace Way, Cincinnati, Ohio 45227 USA, represented XXXXXX, Clinical Trial Manager ("Medpace”); andFakultni nemocnice Kralovske Vinohrady, with its principal office and place of business at Srobarova 1150/50, 100 34 Prague 10, Czech Republic, reference number KH 58/2016, cost center 35019, represented by Asos. Prof. Robert Grill, Ph. D., MHA , Director ("Institution”).Medpace and Institution are sometimes collectively referred to herein as parties (the “Parties”). WHEREAS, Aridis Pharmaceuticals, Inc. with its principal office and place of business 5941 Optical Court, San Jose, CA 95138, USA (“Sponsor”) is sponsoring a clinical study on Aerucin® (aerumab, AR-105) (the “Study Drug”), in accordance with Protocol No. AR-105-002
